IDiyas

For the Inventor, By the Inventor

Hofheim am Taunus, Germany

Hermann J Gerhards

USPTO Granted Patents = 23

Average Co-Inventor Count = 4.3

ph-index = 8

Forward Citations = 154(Granted Patents)


Location History:

  • Hofheim, Taunus, DE (1976 - 1978)
  • Hofheim am Taunus, DE (1980 - 1997)
  • Hofheim am Main, DE (1997)

Company Filing History:

goldMedal22 out of 6,662 
 
Hoechst Aktiengesellschaft
 patents
silverMedal1 out of 1 
 
Hoechst Aktiengeselleschaft
 patent

Years Active: 1976-1997

Loading Chart...
23 patents (USPTO):Explore Patents
1. 5648333 - Peptides having bradykinin antagonist action (1997-07-15),
2. 5635525 - Benzimidazole derivatives as angiotensin II receptor antagonists, (1997-06-03),
3. 5604251 - Imidazole derivatives with a biphenylsulfonylurea or (1997-02-18),
4. 5597803 - Bradykinin peptides with modifications at the N terminus (1997-01-28),
5. 5482957 - Azole derivatives, process for their preparation and their use (1996-01-09),
6. 5444068 - Imidazopyridine derivatives as angiotensin II receptor antagonists, (1995-08-22),
7. 5440046 - Substituted imidazoles (1995-08-08),
8. 5350751 - Substituted imidazoles, pharmaceutical compositions containing these, (1994-09-27),
9. 5225414 - Substituted azoles, a process for their preparation, and their use (1993-07-06),
10. 5100890 - Arylmethylazoles and their salts, agents which contain these compounds, (1992-03-31),
11. 5023357 - Arylmethylazole preparation processes (1991-06-11),
12. 4999352 - 1-(1-aryl-2-hydroxyethyl)-imidazoles and salts thereof, medicaments (1991-03-12),
13. 4876354 - Arylmethylazoles and their salts, processes for their preparation, (1989-10-24),
14. 4762833 - 2,4,6-tris-tertiary-butylamino-1,3,5-triazine useful for the prophylaxis (1988-08-09),
15. 4746661 - Phenylpiperazine propyloxyquinolinones and methods for sedating and (1988-05-24),

Title: Hermann J. Gerhards: A Pioneering Inventor in Pharmaceutical Innovations

Introduction

Hermann J. Gerhards, based in Hofheim am Taunus, Germany, is a prominent inventor in the pharmaceutical field. With a remarkable portfolio of 23 patents, he has significantly contributed to advancements in medicinal chemistry and pharmacology, particularly through the development of various compounds that exhibit therapeutic effects.

Latest Patents

Among his latest innovations, Gerhards has focused on peptides with bradykinin antagonist actions. His work has also included the development of benzimidazole derivatives that act as angiotensin II receptor antagonists. Additionally, he has patented a compound represented by a specific formula, where X denotes a monocyclic radical containing 3, 4, or 5 ring atoms, showcasing his expertise in complex organic chemistry.

Career Highlights

Gerhards has had a noteworthy career with key roles at Hoechst Aktiengesellschaft and Hoechst Aktiengesellschaft. His time at these leading companies has allowed him to further explore and develop pharmaceutical innovations that have potential clinical applications.

Collaborations

Throughout his career, Gerhards has collaborated with distinguished colleagues, including Bernward Scholkens and Adalbert Wagner. These partnerships have fostered an environment of creativity and knowledge-sharing, contributing to the success of their respective projects and innovations.

Conclusion

Hermann J. Gerhards stands out as a talented inventor whose contributions to the pharmaceutical industry are evident through his patents and collaborations. His work not only demonstrates his expertise but also highlights the importance of innovation in improving healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…